TW · Healthcare

Energenesis Biomedical Co. Ltd. (6657)

Biotechnology

Energenesis Biomedical Co. Ltd. (6657) is listed on TW in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6657

P/E ratio

25.00

Energenesis Biomedical Co. Ltd. (6657) — FAQ

What is 6657's P/E ratio?

The price-to-earnings (P/E) ratio for Energenesis Biomedical Co. Ltd. (6657) is 25.00 (data as of 2026-05-23).

Does Energenesis Biomedical Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Energenesis Biomedical Co. Ltd. (6657). Check the MyAverix Finance app for the latest dividend data.

What sector is Energenesis Biomedical Co. Ltd. in?

Energenesis Biomedical Co. Ltd. (6657) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6657 listed on?

6657 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)